Found: 261
Select item for more details and to access through your institution.
Fli1 Deficiency Induces CXCL6 Expression in Dermal Fibroblasts and Endothelial Cells, Contributing to the Development of Fibrosis and Vasculopathy in Systemic Sclerosis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Radiation‐induced cutaneous squamous cell carcinoma showing a significant response to pembrolizumab: A case report.
- Published in:
- Journal of Dermatology, 2024, v. 51, n. 11, p. 1500, doi. 10.1111/1346-8138.17221
- By:
- Publication type:
- Article
LETTERS.
- Published in:
- 2001
- By:
- Publication type:
- Letter
Fli1-haploinsufficient dermal fibroblasts promote skin-localized transdifferentiation of Th2-like regulatory T cells.
- Published in:
- Arthritis Research & Therapy, 2018, v. 20, p. 1, doi. 10.1186/s13075-018-1521-3
- By:
- Publication type:
- Article
The Antimicrobial Peptide Cathelicidin Exerts Immunomodulatory Effects via Scavenger Receptors.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 1, p. 875, doi. 10.3390/ijms24010875
- By:
- Publication type:
- Article
Immunotherapy for Melanoma: The Significance of Immune Checkpoint Inhibitors for the Treatment of Advanced Melanoma.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 24, p. 15720, doi. 10.3390/ijms232415720
- By:
- Publication type:
- Article
Increased Regulatory T Cells and Decreased Myeloid-Derived Suppressor Cells Induced by High CCL17 Levels May Account for Normal Incidence of Cancers among Patients with Atopic Dermatitis.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 4, p. 2025, doi. 10.3390/ijms22042025
- By:
- Publication type:
- Article
TLR2 Deficiency Exacerbates Imiquimod-Induced Psoriasis-Like Skin Inflammation through Decrease in Regulatory T Cells and Impaired IL-10 Production.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 22, p. 8560, doi. 10.3390/ijms21228560
- By:
- Publication type:
- Article
Serum TARC Levels in Patients with Systemic Sclerosis: Clinical Association with Interstitial Lung Disease.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 4, p. 660, doi. 10.3390/jcm10040660
- By:
- Publication type:
- Article
Serum Calponin 3 Levels in Patients with Systemic Sclerosis: Possible Association with Skin Sclerosis and Arthralgia.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 2, p. 280, doi. 10.3390/jcm10020280
- By:
- Publication type:
- Article
The Pathogenesis of Systemic Sclerosis: An Understanding Based on a Common Pathologic Cascade across Multiple Organs and Additional Organ-Specific Pathologies.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 9, p. 2687, doi. 10.3390/jcm9092687
- By:
- Publication type:
- Article
Interleukin-31 promotes fibrosis and T helper 2 polarization in systemic sclerosis.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-26099-w
- By:
- Publication type:
- Article
Vasculopathy in scleroderma.
- Published in:
- Seminars in Immunopathology, 2015, v. 37, n. 5, p. 489, doi. 10.1007/s00281-015-0505-5
- By:
- Publication type:
- Article
Papular interstitial elastolytic giant cell granuloma concomitant with lichen amyloidosus in a type II diabetes patient.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 3, p. 612, doi. 10.1002/jvc2.180
- By:
- Publication type:
- Article
Pyoderma gangrenosum after surgery for forefoot deformity in a patient with rheumatoid arthritis: A case report.
- Published in:
- Modern Rheumatology Case Reports, 2024, v. 8, n. 1, p. 11, doi. 10.1093/mrcr/rxad051
- By:
- Publication type:
- Article
A potential contribution of decreased galectin‐7 expression in stratified epithelia to the development of cutaneous and oesophageal manifestations in systemic sclerosis.
- Published in:
- Experimental Dermatology, 2019, v. 28, n. 5, p. 536, doi. 10.1111/exd.13900
- By:
- Publication type:
- Article
CXCL13 produced by macrophages due to Fli1 deficiency may contribute to the development of tissue fibrosis, vasculopathy and immune activation in systemic sclerosis.
- Published in:
- Experimental Dermatology, 2018, v. 27, n. 9, p. 1030, doi. 10.1111/exd.13724
- By:
- Publication type:
- Article
Transforming growth factor β-inhibitor Repsox downregulates collagen expression of scleroderma dermal fibroblasts and prevents bleomycin-induced mice skin fibrosis.
- Published in:
- Experimental Dermatology, 2017, v. 26, n. 11, p. 1139, doi. 10.1111/exd.13366
- By:
- Publication type:
- Article
The impact of transcription factor Fli1 deficiency on the regulation of angiogenesis.
- Published in:
- Experimental Dermatology, 2017, v. 26, n. 10, p. 912, doi. 10.1111/exd.13341
- By:
- Publication type:
- Article
A potential contribution of altered cathepsin L expression to the development of dermal fibrosis and vasculopathy in systemic sclerosis.
- Published in:
- Experimental Dermatology, 2016, v. 25, n. 4, p. 287, doi. 10.1111/exd.12920
- By:
- Publication type:
- Article
A possible contribution of endothelial CCN1 downregulation due to Fli1 deficiency to the development of digital ulcers in systemic sclerosis.
- Published in:
- Experimental Dermatology, 2015, v. 24, n. 2, p. 127, doi. 10.1111/exd.12602
- By:
- Publication type:
- Article
Serum levels of manganese superoxide dismutase in patients with localized scleroderma.
- Published in:
- Experimental Dermatology, 2004, v. 13, n. 6, p. 357, doi. 10.1111/j.0906-6705.2004.00160.x
- By:
- Publication type:
- Article
Serum Adhesion Molecule Levels as Prognostic Markers in Patients with Early Systemic Sclerosis: A Multicentre, Prospective, Observational Study.
- Published in:
- PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0088150
- By:
- Publication type:
- Article
Fli1 Represses Transcription of the Human α2(I) Collagen Gene by Recruitment of the HDAC1/p300 Complex.
- Published in:
- PLoS ONE, 2013, v. 8, n. 9, p. 1, doi. 10.1371/journal.pone.0074930
- By:
- Publication type:
- Article
Proteasome Inhibitor Bortezomib Ameliorates Intestinal Injury in Mice.
- Published in:
- PLoS ONE, 2012, v. 7, n. 3, p. 1, doi. 10.1371/journal.pone.0034587
- By:
- Publication type:
- Article
A Possible Contribution of Altered Cathepsin B Expression to the Development of Skin Sclerosis and Vasculopathy in Systemic Sclerosis.
- Published in:
- PLoS ONE, 2012, v. 7, n. 2, p. 1, doi. 10.1371/journal.pone.0032272
- By:
- Publication type:
- Article
Lymphangiosarkom der Hüfte in einem nicht bestrahlten kongenitalen Lymphangiom.
- Published in:
- Journal der Deutschen Dermatologischen Gesellschaft, 2017, v. 15, n. 12, p. 1235, doi. 10.1111/ddg.13356_g
- By:
- Publication type:
- Article
Lymphangiosarcoma of the hip arising in a congenital non-irradiated lymphangioma.
- Published in:
- Journal der Deutschen Dermatologischen Gesellschaft, 2017, v. 15, n. 12, p. 1235, doi. 10.1111/ddg.13356
- By:
- Publication type:
- Article
A possible implication of reduced levels of LIF, LIFR, and gp130 in vasculopathy related to systemic sclerosis.
- Published in:
- Archives of Dermatological Research, 2017, v. 309, n. 10, p. 833, doi. 10.1007/s00403-017-1786-4
- By:
- Publication type:
- Article
BET bromodomain inhibitor JQ1 decreases CD30 and CCR4 expression and proliferation of cutaneous T-cell lymphoma cell lines.
- Published in:
- Archives of Dermatological Research, 2017, v. 309, n. 6, p. 491, doi. 10.1007/s00403-017-1749-9
- By:
- Publication type:
- Article
Increased syndecan-4 expression in sera and skin of patients with atopic dermatitis.
- Published in:
- Archives of Dermatological Research, 2016, v. 308, n. 9, p. 655, doi. 10.1007/s00403-016-1683-2
- By:
- Publication type:
- Article
TOX expression in different subtypes of cutaneous lymphoma.
- Published in:
- Archives of Dermatological Research, 2014, v. 306, n. 9, p. 843, doi. 10.1007/s00403-014-1501-7
- By:
- Publication type:
- Article
Fli1 deficiency contributes to the suppression of endothelial CXCL5 expression in systemic sclerosis.
- Published in:
- Archives of Dermatological Research, 2014, v. 306, n. 4, p. 331, doi. 10.1007/s00403-013-1431-9
- By:
- Publication type:
- Article
Clinical significance of serum soluble Tie1 levels in patients with systemic sclerosis.
- Published in:
- Archives of Dermatological Research, 2013, v. 305, n. 4, p. 325, doi. 10.1007/s00403-012-1307-4
- By:
- Publication type:
- Article
Increased production of soluble inducible costimulator in patients with diffuse cutaneous systemic sclerosis.
- Published in:
- Archives of Dermatological Research, 2013, v. 305, n. 1, p. 17, doi. 10.1007/s00403-012-1292-7
- By:
- Publication type:
- Article
A possible contribution of elevated serum clusterin levels to the inhibition of digital ulcers and pulmonary arterial hypertension in systemic sclerosis.
- Published in:
- Archives of Dermatological Research, 2012, v. 304, n. 6, p. 459, doi. 10.1007/s00403-012-1219-3
- By:
- Publication type:
- Article
Angiogenin levels are increased in lesional skin and sera in patients with erythrodermic cutaneous T cell lymphoma.
- Published in:
- Archives of Dermatological Research, 2012, v. 304, n. 5, p. 401, doi. 10.1007/s00403-012-1238-0
- By:
- Publication type:
- Article
Clinical significance of circulating platelet-activating factor acetylhydrolase levels in systemic sclerosis.
- Published in:
- Archives of Dermatological Research, 2012, v. 304, n. 3, p. 203, doi. 10.1007/s00403-011-1196-y
- By:
- Publication type:
- Article
Serum CCL23 levels are increased in patients with systemic sclerosis.
- Published in:
- Archives of Dermatological Research, 2011, v. 303, n. 1, p. 29, doi. 10.1007/s00403-010-1078-8
- By:
- Publication type:
- Article
Serum matrix metalloproteinase-3 in systemic sclerosis.
- Published in:
- Archives of Dermatological Research, 2004, v. 296, n. 1, p. 25, doi. 10.1007/s00403-004-0468-1
- By:
- Publication type:
- Article
Anti-U1RNP antibodies in patients with localized scleroderma.
- Published in:
- Archives of Dermatological Research, 2001, v. 293, n. 9, p. 455, doi. 10.1007/s004030100254
- By:
- Publication type:
- Article
The Evaluation of Immune Checkpoint Inhibitors and BRAF/MEK Inhibitors in Different Therapy Lines for Metastatic Melanoma: A Retrospective Study.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 18, p. 5560, doi. 10.3390/jcm13185560
- By:
- Publication type:
- Article
Biologics for Reducing Cardiovascular Risk in Psoriasis Patients.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 3, p. 1162, doi. 10.3390/jcm12031162
- By:
- Publication type:
- Article
Single- cell- level protein analysis revealing the roles of autoantigen- reactive B lymphocytes in autoimmune disease and the murine.
- Published in:
- eLife, 2021, p. 1, doi. 10.7554/eLife.67209
- By:
- Publication type:
- Article
A phase II multicentre study of plasminogen activator inhibitor-1 inhibitor (TM5614) plus nivolumab for treating anti-programmed cell death 1 antibody-refractory malignant melanoma: TM5614-MM trial.
- Published in:
- British Journal of Dermatology, 2024, v. 191, n. 5, p. 691, doi. 10.1093/bjd/ljae231
- By:
- Publication type:
- Article
Postoperative adjuvant therapy for 120 patients with melanoma, including acral and mucosal subtypes: a multicentre, observational study of 2-year follow-up results.
- Published in:
- British Journal of Dermatology, 2023, v. 189, n. 4, p. 476, doi. 10.1093/bjd/ljad183
- By:
- Publication type:
- Article
Tenascin-C upregulation by transforming growth factor-ß in human dermal fibroblasts involves Smad3, Sp1, and Ets1.
- Published in:
- Oncogene, 2004, v. 23, n. 9, p. 1656, doi. 10.1038/sj.onc.1207064
- By:
- Publication type:
- Article
Assessment of endothelial function during the loading phase of infliximab in psoriasis: a potential predictor of its drug survival.
- Published in:
- International Journal of Dermatology, 2019, v. 58, n. 1, p. 54, doi. 10.1111/ijd.14200
- By:
- Publication type:
- Article
Anti-agalactosyl immunoglobulin G antibodies in localized scleroderma.
- Published in:
- International Journal of Dermatology, 2005, v. 44, n. 10, p. 817, doi. 10.1111/j.1365-4632.2005.02584.x
- By:
- Publication type:
- Article
Three-Year Analysis of Adjuvant Therapy in Postoperative Melanoma including Acral and Mucosal Subtypes.
- Published in:
- Cancers, 2024, v. 16, n. 15, p. 2755, doi. 10.3390/cancers16152755
- By:
- Publication type:
- Article